Peter Matt

4.7k citations

95 papers · 3.8k indexed · 1 hit paper · h-index 25

Impact in

Inorganic Chemistry top 1%
- Asymmetric Hydrogenation and Catalysis
Organic Chemistry top 0.5%
- Asymmetric Synthesis and Catalysis
- Synthetic Organic Chemistry Methods
- Synthesis and Catalytic Reactions
- Cyclopropane Reaction Mechanisms
- Catalytic C–H Functionalization Methods
- Organometallic Complex Synthesis and Catalysis

Papers in ⓘ

Surgery 25
- Cardiac and Coronary Surgery Techniques 12
Cardiology and Cardiovascular Medicine 24
- Cardiac Valve Diseases and Treatments 15
- Cardiac, Anesthesia and Surgical Outcomes 7

Co-authors: Andreas Pfaltz (8 shared papers)David A. Evans (4 shared papers)Scott J. Miller (4 shared papers)Thomas Lectka (2 shared papers)Roger D. Norcross (4 shared papers)Jerry A. Murry (3 shared papers)Urs Leutenegger (1 shared paper)Christoph J. Fahrni (1 shared paper)
Journals: The Thoracic and Cardiovascular Surgeon (8 papers)European Journal of Cardio-Thoracic Surgery (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Interactive Cardiovascular and Thoracic Surgery (3 papers)The Annals of Thoracic Surgery (3 papers)
Partner nations: Switzerland United States Germany

In The Last Decade

Peter Matt

89 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Chiral Phosphinoaryldihydrooxazoles as Ligands in Asymmetric Catalysis: Pd‐Catalyzed Allylic Substitution 1993 · 608 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1993 Angewandte Chemie International Edition in English

Peers

Countries citing papers authored by Peter Matt

Since Specialization

Citations

This map shows the geographic impact of Peter Matt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Matt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Matt more than expected).

Fields of papers citing papers by Peter Matt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Matt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Matt. The network helps show where Peter Matt may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Matt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Matt Line = papers co-authored together Peter Matt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Chiral Phosphinoaryldihydrooxazoles as Ligands in Asymmetric Catalysis: Pd‐Catalyzed Allylic Substitution Angewandte Chemie International Edition in English ·Peter Matt, Andreas Pfaltz Hit paper breakdown →	1993	608
2	Chiral Bis(oxazoline)copper(II) Complexes as Lewis Acid Catalysts for the Enantioselective Diels−Alder Reaction Journal of the American Chemical Society ·David A. Evans, Scott J. Miller, Thomas Lectka, Peter Matt	1999	285
3	C₂‐Symmetric Cationic Copper(II) Complexes as Chiral Lewis Acids: Counterion Effects in the Enantioselective Diels–Alder Reaction Angewandte Chemie International Edition in English ·David A. Evans, Jerry A. Murry, Peter Matt, Roger D. Norcross, Scott J. Miller	1995	261
4	5-aza-semicorrins: A new class of bidentate nitrogen ligands for enantioselective catalysis Tetrahedron ·Urs Leutenegger, Gisela Umbricht, Christoph J. Fahrni, Peter Matt, Andreas Pfaltz	1992	250
5	Enantioselective Allylic Substitution Catalyzed by Chiral [Bis(dihydrooxazole)]palladium Complexes: Catalyst structure and possible mechanism of enantioselection Helvetica Chimica Acta ·Peter Matt, Guy C. Lloyd‐Jones, Alexander B. E. Minidis, Andreas Pfaltz, Ludwig Macko, Markus Neuburger, Margareta Zehnder, Heinz Rüegger, Paul S. Pregosin	1995	222
6	Bis(oxazoline) and Bis(oxazolinyl)pyridine Copper Complexes as Enantioselective Diels−Alder Catalysts: Reaction Scope and Synthetic Applications Journal of the American Chemical Society ·David A. Evans, David M. Barnes, Jeffrey S. Johnson, Thomas Lectka, Peter Matt, Scott J. Miller, Jerry A. Murry, Roger D. Norcross, Eileen A. Shaughnessy, Kevin R. Campos	1999	214
7	Circulating Transforming Growth Factor-β in Marfan Syndrome Circulation ·Peter Matt, Florian Schoenhoff, Jennifer Habashi, Tammy M. Holm, Christel van Erp, David Loch, Olga D. Carlson, Benjamin F. Griswold, Qin Fu, Julie De Backer, Bart Loeys, David L. Huso, Nazli B. McDonnell, Jennifer E. Van Eyk, Harry C. Dietz	2009	210
8	Chirale Phosphinoaryldihydrooxazole als Liganden in der asymmetrischen Katalyse: Pd‐katalysierte allylische Substitution Angewandte Chemie ·Peter Matt, Andreas Pfaltz	1993	167
9	Enantioselective allylic amination with chiral (phosphino-oxazoline)pd catalysts Tetrahedron Asymmetry ·Peter Matt, Olivier Loiseleur, Guido Koch, Andreas Pfaltz, Claudia Lefeber, Thomas Feucht, Günter Helmchen	1994	152
10	Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis Bone Marrow Transplantation ·Frank Reichenberger, James Habicht, Peter Matt, Reno Frei, M. Solèr, C.T. Bolliger, Peter Dalquen, Aloïs Gratwohl, M. Tamm	1999	111
11	Discovery of 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes Journal of Medicinal Chemistry ·Jürgen Wagner, Peter Matt, Richard Sedrani, Rainer Albert, Nigel G. Cooke, Claus Ehrhardt, Martin Geiser, Gabriele Rummel, Wilhelm Stark, André Strauss, Sandra W. Cowan‐Jacob, Christian Beerli, Gisbert Weckbecker, Jean-Pierre Evenou, Gerhard Zenke, Sylvain Cottens	2009	104
12	Argyrins, Immunosuppressive Cyclic Peptides from Myxobacteria. I. Production, Isolation, Physico-chemical and Biological Properties. The Journal of Antibiotics ·Florenz Sasse, Heinrich Steinmetz, Thomas Schupp, Frank Petersen, Klaus Memmert, Hans Hofmann, Christoph Heusser, Volker Brinkmann, Peter Matt, Gerhard Höfle, Hans Reichenbach	2002	87
13	Biomarker discovery: proteome fractionation and separation in biological samples Physiological Genomics ·Peter Matt, Zongming Fu, Qin Fu, Jennifer E. Van Eyk	2007	69
14	Recent advances in understanding Marfan syndrome: Should we now treat surgical patients with losartan? Journal of Thoracic and Cardiovascular Surgery ·Peter Matt, Jennifer Habashi, Thierry Carrel, Duke E. Cameron, Jennifer E. Van Eyk, Harry C. Dietz	2008	61
15	Transfusion of Allogeneic Blood Products in Proximal Aortic Surgery With Hypothermic Circulatory Arrest: Effect of Thromboelastometry-Guided Transfusion Management Journal of Cardiothoracic and Vascular Anesthesia ·Jens Faßl, Peter Matt, Friedrich Eckstein, Miodrag Filipovic, Michael Gregor, Urs Zenklusen, Manfred D. Seeberger, Daniel Bolliger	2013	52
16	Predicting Outcome After Lung Resection for Invasive Pulmonary Aspergillosis in Patients With Neutropenia CHEST Journal ·Peter Matt, Franziska Bernet, James Habicht, Franco Gambazzi, Aloïs Gratwohl, Hans‐Reinhard Zerkowski, Michael Tamm	2004	49
17	Enantioselective conjugate reduction of α,β-unsaturated carboxamides with semicorrin cobalt catalysts Tetrahedron Asymmetry ·Peter Matt, Andreas Pfaltz	1991	49
18	C₂‐Symmetrische, kationische Kupfer(II)‐Komplexe als chirale Lewis‐Säuren – Einfluß des Gegenions bei enantioselektiven Diels‐Alder‐Reaktionen Angewandte Chemie ·David A. Evans, Jerry A. Murry, Peter Matt, Roger D. Norcross, Scott J. Miller	1995	48
19	Argyrins, Immunosuppressive Cyclic Peptides from Myxobacteria. II. Structure Elucidation and Stereochemistry. The Journal of Antibiotics ·Larissa Vollbrecht, Heinrich Steinmetz, Gerhard Höfle, Lukas Oberer, Grety Rihs, Günter Bovermann, Peter Matt	2002	46
20	Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis Clinical Immunology ·Kajsa E. Prokopec, Mia Rhodiner, Peter Matt, Ulla Lindqvist, Sandra Kleinau	2010	36

About Peter Matt

Peter Matt is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (15 papers), Cardiac and Coronary Surgery Techniques (12 papers), Asymmetric Synthesis and Catalysis (11 papers), Aortic Disease and Treatment Approaches (11 papers), Aortic aneurysm repair treatments (10 papers), German Literature and Culture Studies (8 papers), Cardiac, Anesthesia and Surgical Outcomes (7 papers) and Asymmetric Hydrogenation and Catalysis (7 papers). The work is most often cited by research in Inorganic Chemistry (1.1k citations), Organic Chemistry (2.3k citations), Process Chemistry and Technology (47 citations), Molecular Biology (906 citations) and Spectroscopy (195 citations). Peter Matt has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Andreas Pfaltz, David A. Evans, Scott J. Miller, Thomas Lectka, Roger D. Norcross, Jerry A. Murry, Urs Leutenegger, Christoph J. Fahrni, Gisela Umbricht and Jennifer E. Van Eyk. Their work appears in journals such as The Thoracic and Cardiovascular Surgeon, European Journal of Cardio-Thoracic Surgery, Bioorganic & Medicinal Chemistry Letters, Interactive Cardiovascular and Thoracic Surgery and The Annals of Thoracic Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact